These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacogenetic considerations in the treatment of psychiatric disorders. Lohoff FW; Ferraro TN Expert Opin Pharmacother; 2010 Feb; 11(3):423-39. PubMed ID: 20102306 [TBL] [Abstract][Full Text] [Related]
3. [Development of antituberculous drugs: current status and future prospects]. Tomioka H; Namba K Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921 [TBL] [Abstract][Full Text] [Related]
4. Alternative strategies in drug development: clinical pharmacological aspects. Kuhlmann J Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949 [TBL] [Abstract][Full Text] [Related]
5. The promise and reality of pharmacogenetics in psychiatry. Zandi PP; Judy JT Clin Lab Med; 2010 Dec; 30(4):931-74. PubMed ID: 20832660 [TBL] [Abstract][Full Text] [Related]
6. [Personalized medicine in psychiatry -- an old concept from a new aspect]. Molnar JM Neuropsychopharmacol Hung; 2012 Mar; 14(1):2-3. PubMed ID: 22427465 [No Abstract] [Full Text] [Related]
7. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification. Smart A; Martin P Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196 [TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics in neuropsychiatric diseases: epilepsy as a model. Depondt C Acta Neurol Belg; 2006 Dec; 106(4):157-67. PubMed ID: 17323833 [TBL] [Abstract][Full Text] [Related]
9. Implications of pharmacogenomics for drug development. Kirk RJ; Hung JL; Horner SR; Perez JT Exp Biol Med (Maywood); 2008 Dec; 233(12):1484-97. PubMed ID: 18849536 [TBL] [Abstract][Full Text] [Related]
10. Failed drug discovery in psychiatry: time for human genome-guided solutions. Papassotiropoulos A; de Quervain DJ Trends Cogn Sci; 2015 Apr; 19(4):183-7. PubMed ID: 25727774 [TBL] [Abstract][Full Text] [Related]
11. Towards a clinical methodology for neuropsychopharmacological research. Ban TA Neuropsychopharmacol Hung; 2007 Jun; 9(2):81-90. PubMed ID: 17970531 [TBL] [Abstract][Full Text] [Related]
12. The relevance of Caenorhabditis elegans genetics for understanding human psychiatric disease. Wang X; Sliwoski GR; Buttner EA Harv Rev Psychiatry; 2011; 19(4):210-8. PubMed ID: 21790269 [No Abstract] [Full Text] [Related]
13. New directions for drug discovery. Spedding M Dialogues Clin Neurosci; 2006; 8(3):295-301. PubMed ID: 17117611 [TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics, race, and psychiatry: prospects and challenges. Jones DS; Perlis RH Harv Rev Psychiatry; 2006; 14(2):92-108. PubMed ID: 16603475 [TBL] [Abstract][Full Text] [Related]
15. Perlegen sciences, inc. Peacock E; Whiteley P Pharmacogenomics; 2005 Jun; 6(4):439-42. PubMed ID: 16004563 [TBL] [Abstract][Full Text] [Related]
16. The information revolution reaches pharmaceuticals: balancing innovation incentives, cost, and access in the post-genomics era. Rai AK Univ Ill Law Rev; 2001; 2001(1):173-210. PubMed ID: 16493845 [TBL] [Abstract][Full Text] [Related]
17. Genomics and the future of pharmacotherapy in psychiatry. Malhotra AK; Lencz T; Correll CU; Kane JM Int Rev Psychiatry; 2007 Oct; 19(5):523-30. PubMed ID: 17896232 [TBL] [Abstract][Full Text] [Related]
18. Nurses' genetic/genomics competencies when medication therapy is guided by pharmacogenetic testing: children with mental health disorders as an exemplar. Prows CA; SaldaƱa SN J Pediatr Nurs; 2009 Jun; 24(3):179-88. PubMed ID: 19467430 [TBL] [Abstract][Full Text] [Related]
19. What is the role of pharmacogenetics in clinical psychiatry? Lombard J; Doraiswamy PM Expert Opin Drug Metab Toxicol; 2013 Jan; 9(1):1-4. PubMed ID: 23189950 [TBL] [Abstract][Full Text] [Related]